Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL - PubMed (original) (raw)

Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL

Alexander Hergovich et al. Nat Cell Biol. 2003 Jan.

Abstract

Von Hippel-Lindau (VHL) tumour suppressor gene inactivation is linked to the development of haemangioblastomas in the central nervous system and retina, often in association with other tumours, such as clear-cell carcinomas of the kidney and phaeochromocytomas. Here we show that the VHL protein (pVHL) is a microtubule-associated protein that can protect microtubules from depolymerization in vivo. Both the microtubule binding and stabilization functions of pVHL depend on amino acids 95-123 of pVHL, a mutational 'hot-spot' in VHL disease. From analysis of naturally occurring pVHL mutants, it seems that only point mutations such as pVHL(Y98H) and pVHL(Y112H) (that predispose to haemangioblastoma and phaeochromocytoma, but not to renal cell carcinoma) disrupt pVHL's microtubule-stabilizing function. Our data identify a role for pVHL in the regulation of microtubule dynamics and potentially provide a link between this function of pVHL and the pathogenesis of haemangioblastoma and phaeochromocytoma in the context of VHL disease.

PubMed Disclaimer

Comment in

• New insights into an enigmatic tumour suppressor.
  Ratcliffe PJ. Ratcliffe PJ. Nat Cell Biol. 2003 Jan;5(1):7-8. doi: 10.1038/ncb0103-7. Nat Cell Biol. 2003. PMID: 12511881 No abstract available.

Similar articles

• Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
  Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER. Zatyka M, et al. Cancer Res. 2002 Jul 1;62(13):3803-11. Cancer Res. 2002. PMID: 12097293
• The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.
  Pause A, Lee S, Worrell RA, Chen DY, Burgess WH, Linehan WM, Klausner RD. Pause A, et al. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2156-61. doi: 10.1073/pnas.94.6.2156. Proc Natl Acad Sci U S A. 1997. PMID: 9122164 Free PMC article.
• Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.
  Clifford SC, Cockman ME, Smallwood AC, Mole DR, Woodward ER, Maxwell PH, Ratcliffe PJ, Maher ER. Clifford SC, et al. Hum Mol Genet. 2001 May 1;10(10):1029-38. doi: 10.1093/hmg/10.10.1029. Hum Mol Genet. 2001. PMID: 11331613
• The von Hippel-Lindau tumor suppressor gene and kidney cancer.
  Kaelin WG Jr. Kaelin WG Jr. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6290S-5S. doi: 10.1158/1078-0432.CCR-sup-040025. Clin Cancer Res. 2004. PMID: 15448019 Review.
• The von Hippel-Lindau tumour suppressor protein: new perspectives.
  Ohh M, Kaelin WG Jr. Ohh M, et al. Mol Med Today. 1999 Jun;5(6):257-63. doi: 10.1016/s1357-4310(99)01481-1. Mol Med Today. 1999. PMID: 10366821 Review.

Cited by

• HIF Stabilization Weakens Primary Cilia.
  Resnick A. Resnick A. PLoS One. 2016 Nov 3;11(11):e0165907. doi: 10.1371/journal.pone.0165907. eCollection 2016. PLoS One. 2016. PMID: 27812213 Free PMC article.
• Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization.
  Zheng X, Ruas JL, Cao R, Salomons FA, Cao Y, Poellinger L, Pereira T. Zheng X, et al. Mol Cell Biol. 2006 Jun;26(12):4628-41. doi: 10.1128/MCB.02236-05. Mol Cell Biol. 2006. PMID: 16738327 Free PMC article.
• Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability.
  Thoma CR, Matov A, Gutbrodt KL, Hoerner CR, Smole Z, Krek W, Danuser G. Thoma CR, et al. J Cell Biol. 2010 Sep 20;190(6):991-1003. doi: 10.1083/jcb.201006059. J Cell Biol. 2010. PMID: 20855504 Free PMC article.
• Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.
  Rankin EB, Higgins DF, Walisser JA, Johnson RS, Bradfield CA, Haase VH. Rankin EB, et al. Mol Cell Biol. 2005 Apr;25(8):3163-72. doi: 10.1128/MCB.25.8.3163-3172.2005. Mol Cell Biol. 2005. PMID: 15798202 Free PMC article.
• Concomitant deregulation of HIF1alpha and cell cycle proteins in VHL-mutated renal cell carcinomas.
  Atkins DJ, Gingert C, Justenhoven C, Schmahl GE, Bonato MS, Brauch H, Störkel S. Atkins DJ, et al. Virchows Arch. 2005 Sep;447(3):634-42. doi: 10.1007/s00428-005-1262-y. Epub 2005 Jul 1. Virchows Arch. 2005. PMID: 15991006

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource